Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 4/2019

24.04.2019 | Short Communication

High Prevalence of Celiac Disease in Patients with Immune Thrombocytopenia

verfasst von: Parathan Karunakaran, Rakesh Kochhar, Sadhna Lal, Ram V. Nampoothiri, Neelam Varma, Subhash Varma, Pankaj Malhotra

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Celiac disease (CD) is known to be associated with several autoimmune disorders. We studied the prevalence of subclinical CD among patients with immune thrombocytopenia (ITP) as compared to general population. Cases of primary ITP between the age group of 18–60 years were studied. Besides clinical examination, all patients underwent serology testing for tissue transglutaminase antibody (tTG) IgA and anti-endomysial antibodies IgA. The diagnosis of CD was made if both antibodies were positive. Healthy subjects acted as controls and underwent serological testing for tTG IgA. Seventy-nine primary ITP and 316 healthy subjects underwent serology testing for CD. Four patients of primary ITP (4/79) were positive for both serology as compared to 2 (2/316) healthy controls [odds ratio 8.37 (CI 1.50–46.47, p < 0.005)]. Among the ITP cases only one had clinical symptoms of CD while none of the healthy controls had symptoms of CD. There is a significantly higher prevalence of subclinical CD in patients with ITP. Since the prevalence of CD is known to vary among different geographical zones, we suggest further studies on screening of ITP patients for CD in areas of high prevalence.
Literatur
1.
Zurück zum Zitat Sood A, Midha V, Sood N, Kaushal V, Puri H (2001) Increasing incidence of celiac disease in India. Am J Gastroenterol 96(9):2804–2805CrossRef Sood A, Midha V, Sood N, Kaushal V, Puri H (2001) Increasing incidence of celiac disease in India. Am J Gastroenterol 96(9):2804–2805CrossRef
2.
Zurück zum Zitat Varma S, Malhotra P, Kochhar R, Varma N, Kumari S, Jain S (2001) Celiac disease presenting as iron-deficiency anemia in northern India. Indian J Gastroenterol 20(6):234–236PubMed Varma S, Malhotra P, Kochhar R, Varma N, Kumari S, Jain S (2001) Celiac disease presenting as iron-deficiency anemia in northern India. Indian J Gastroenterol 20(6):234–236PubMed
3.
Zurück zum Zitat Barton SH, Murray JA (2008) Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am 37(2):411–428CrossRef Barton SH, Murray JA (2008) Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am 37(2):411–428CrossRef
4.
Zurück zum Zitat Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393CrossRef Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393CrossRef
5.
Zurück zum Zitat Page LK, Psaila B, Provan D, Michael Hamilton J, Jenkins JM, Elish AS et al (2007) The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 138(2):245–248CrossRef Page LK, Psaila B, Provan D, Michael Hamilton J, Jenkins JM, Elish AS et al (2007) The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 138(2):245–248CrossRef
6.
Zurück zum Zitat Wolters V, Vooijs-Moulaert AF, Burger H, Brooimans R, De Schryver J, Rijkers G et al (2002) Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease. Eur J Pediatr 161(5):284–287CrossRef Wolters V, Vooijs-Moulaert AF, Burger H, Brooimans R, De Schryver J, Rijkers G et al (2002) Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease. Eur J Pediatr 161(5):284–287CrossRef
7.
Zurück zum Zitat Yiannakou JY, Dell’Olio D, Saaka M, Ellis HJ, Rosen-Bronson S, Dumonde DC et al (1997) Detection and characterisation of anti-endomysial antibody in coeliac disease using human umbilical cord. Int Arch Allergy Immunol 112(2):140–144CrossRef Yiannakou JY, Dell’Olio D, Saaka M, Ellis HJ, Rosen-Bronson S, Dumonde DC et al (1997) Detection and characterisation of anti-endomysial antibody in coeliac disease using human umbilical cord. Int Arch Allergy Immunol 112(2):140–144CrossRef
8.
Zurück zum Zitat Kochhar R, Sachdev S, Aggarwal A, Sharma V, Prasad KK, Singh G et al (2012) Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis 44(6):530–532CrossRef Kochhar R, Sachdev S, Aggarwal A, Sharma V, Prasad KK, Singh G et al (2012) Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis 44(6):530–532CrossRef
9.
Zurück zum Zitat Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A et al (2011) Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol 26(5):894–900CrossRef Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A et al (2011) Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol 26(5):894–900CrossRef
10.
Zurück zum Zitat Hauser GJ, Heiman I, Laurian L, Diamant S, Spirer Z (1981) Selective IgA deficiency with multiple autoimmune disorders. J Clin Lab Immunol 6(1):81–85PubMed Hauser GJ, Heiman I, Laurian L, Diamant S, Spirer Z (1981) Selective IgA deficiency with multiple autoimmune disorders. J Clin Lab Immunol 6(1):81–85PubMed
11.
Zurück zum Zitat Kahn O, Fiel MI, Janowitz HD (1996) Celiac sprue, idiopathic thrombocytopenic purpura, and hepatic granulomatous disease. An autoimmune linkage? J Clin Gastroenterol. 23(3):214–216CrossRef Kahn O, Fiel MI, Janowitz HD (1996) Celiac sprue, idiopathic thrombocytopenic purpura, and hepatic granulomatous disease. An autoimmune linkage? J Clin Gastroenterol. 23(3):214–216CrossRef
12.
Zurück zum Zitat Williams SF, Mincey BA, Calamia KT (2003) Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura. South Med J 96(7):721–723CrossRef Williams SF, Mincey BA, Calamia KT (2003) Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura. South Med J 96(7):721–723CrossRef
13.
Zurück zum Zitat Fisgin T, Yarali N, Duru F, Usta B, Kara A (2004) Hematologic manifestation of childhood celiac disease. Acta Haematol 111(4):211–214CrossRef Fisgin T, Yarali N, Duru F, Usta B, Kara A (2004) Hematologic manifestation of childhood celiac disease. Acta Haematol 111(4):211–214CrossRef
14.
Zurück zum Zitat Dogan M, Sal E, Akbayram S, Peker E, Cesur Y, Oner AF (2011) Concurrent celiac disease, idiopathic thrombocytopenic purpura and autoimmune thyroiditis: a case report. Clin Appl Thromb Hemost 17(6):E13–E16CrossRef Dogan M, Sal E, Akbayram S, Peker E, Cesur Y, Oner AF (2011) Concurrent celiac disease, idiopathic thrombocytopenic purpura and autoimmune thyroiditis: a case report. Clin Appl Thromb Hemost 17(6):E13–E16CrossRef
15.
Zurück zum Zitat Hammami S, Hadded S, Lajmi K, Besbes LG, Meriem CB, Chouchane S et al (2011) Immune thrombocytopenic purpure and coeliac disease. J Paediatr Child Health 47(4):240CrossRef Hammami S, Hadded S, Lajmi K, Besbes LG, Meriem CB, Chouchane S et al (2011) Immune thrombocytopenic purpure and coeliac disease. J Paediatr Child Health 47(4):240CrossRef
16.
Zurück zum Zitat Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O (2008) Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets 19(4):252–257CrossRef Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O (2008) Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets 19(4):252–257CrossRef
17.
Zurück zum Zitat Olen O, Montgomery SM, Elinder G, Ekbom A, Ludvigsson JF (2008) Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand J Gastroenterol 43(4):416–422CrossRef Olen O, Montgomery SM, Elinder G, Ekbom A, Ludvigsson JF (2008) Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand J Gastroenterol 43(4):416–422CrossRef
18.
Zurück zum Zitat Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M (1996) Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 41(1):83–87CrossRef Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M (1996) Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 41(1):83–87CrossRef
Metadaten
Titel
High Prevalence of Celiac Disease in Patients with Immune Thrombocytopenia
verfasst von
Parathan Karunakaran
Rakesh Kochhar
Sadhna Lal
Ram V. Nampoothiri
Neelam Varma
Subhash Varma
Pankaj Malhotra
Publikationsdatum
24.04.2019
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01120-x

Weitere Artikel der Ausgabe 4/2019

Indian Journal of Hematology and Blood Transfusion 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.